Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 2Phase EARLY_PHASE1 1

Status

Recruiting 56Unknown 35Active not recruiting 13Terminated 8Not yet recruiting 6Completed 5Withdrawn 4

Sponsor Class

OTHER 6

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Lymphoid 4Plasma cell 1Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Lymphoma 2Burkitt Lymphoma 2Recurrence 1Pancreatic Neoplasms 1Multiple Myeloma 1Lymphoma, B-Cell 1Leukemia 1Carcinoma, Pancreatic Ductal 1

Interventions

Cisplatin 122Carboplatin 120Drug Therapy 104Bevacizumab 101Capecitabine 96Oxaliplatin 95Radiotherapy 92Gemcitabine 88Paclitaxel 87tislelizumab 84Cyclophosphamide 83Specimen Handling 80pembrolizumab 76toripalimab 66Magnetic Resonance Spectroscopy 63Fluorouracil 61sintilimab 58Injections 57anlotinib 51Docetaxel 51Surgical Procedures, Operative 48130-nm albumin-bound paclitaxel 48fludarabine 45Pemetrexed 43Standard of Care 42Biopsy 42venetoclax 41Irinotecan 41lenvatinib 40Leucovorin 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Immunotherapy, Adoptive × Clear all
NCT07458659 2026-03-09

CART-BCMA

Chulalongkorn University

Phase EARLY_PHASE1 Not yet recruiting
3 enrolled
Plasma cell

Multiple Myeloma

NCT07153289 2025-09-03

ResCPa

University Hospital Tuebingen

Phase 1/2 Not yet recruiting
38 enrolled
Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

NCT07043218 2025-06-29

A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Shanghai Tongji Hospital, Tongji University School of Medicine

Phase 1 Not yet recruiting
36 enrolled
Lymphoid

Burkitt Lymphoma

NCT07032324 2025-06-23

CT1190B

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1 Not yet recruiting
27 enrolled
Lymphoid

Lymphoma, B-Cell

NCT07020260 2025-06-13

PACMAN

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Not yet recruiting
18 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Lymphoma

NCT06647329 2024-10-17

CAR-T Therapy

Zhengzhou University

Phase 1 Not yet recruiting
30 enrolled
Lymphoid

Lymphoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡